Education
About Us
Working with TipRanks
Follow Us
Altria Group Inc (DE:PHM7)
XETRA:PHM7
PHM7 Stock Chart & Stats
€58.39
-€0.17(-0.33%)
At close: 4:00 PM EST
€58.39
-€0.17(-0.33%)
Day’s Range― - ―
52-Week Range€46.62 - €59.54
Previous CloseN/A
Volume2.27K
Average Volume (3M)8.04K
Market Cap
€99.05B
Enterprise Value€135.55B
Total Cash (Recent Filing)€4.47B
Total Debt (Recent Filing)€25.71B
Price to Earnings (P/E)13.9
Beta0.17
Next Earnings
Apr 30, 2026EPS Estimate
1.07Next Dividend Ex-DateN/A
Dividend Yield7.26%
Share Statistics
EPS (TTM)1.12
Shares Outstanding1,671,898,100
10 Day Avg. Volume4,565
30 Day Avg. Volume8,045
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)-27.61
Price to Sales (P/S)4.80
P/FCF Ratio10.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€57.62Price Target Upside-1.32% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)4.82
Revenue Forecast (FY)€17.40B
Bulls Say, Bears Say
Bulls Say
Capital Allocation And ValuationA relatively low valuation and a strong balance sheet create scope for increased share repurchases while a high dividend yield supports shareholder returns and limits downside risk.
Regulatory ApprovalFDA authorization of on! PLUS enables Altria to accelerate its shift toward smoke-free products and expand in the nicotine pouch category, supporting potential revenue diversification.
Tax And Duty BenefitsRising duty drawback benefits from increased import and export activity are expected to bolster adjusted earnings and help offset margin pressure from pricing investments.
Bears Say
Competitive Risk In Reduced-risk ProductsLimited progress on reduced-risk product offerings leaves the company vulnerable to market share losses from competitors' heated tobacco and other smoke-free product launches.
Regulatory And Legal RiskMultiple federal investigations and secular decreases in cigarette smoking present regulatory and structural risks that could dampen investor sentiment and constrain valuation.
Volume And Product Mix PressureOngoing declines in premium cigarette volumes and growth concentrated in discount brands produce a negative product mix that can weigh on revenue and margins.
Altria Group News
PHM7 FAQ
What was Altria Group Inc’s price range in the past 12 months?
Altria Group Inc lowest stock price was €46.62 and its highest was €59.54 in the past 12 months.
What is Altria Group Inc’s market cap?
Altria Group Inc’s market cap is €99.05B.
When is Altria Group Inc’s upcoming earnings report date?
Altria Group Inc’s upcoming earnings report date is Apr 30, 2026 which is in 56 days.
How were Altria Group Inc’s earnings last quarter?
Altria Group Inc released its earnings results on Jan 29, 2026. The company reported €1.118 earnings per share for the quarter, missing the consensus estimate of €1.134 by -€0.016.
Is Altria Group Inc overvalued?
According to Wall Street analysts Altria Group Inc’s price is currently Overvalued.
Does Altria Group Inc pay dividends?
Altria Group Inc pays a Quarterly dividend of €0.901 which represents an annual dividend yield of 7.26%. See more information on Altria Group Inc dividends here
What is Altria Group Inc’s EPS estimate?
Altria Group Inc’s EPS estimate is 1.07.
How many shares outstanding does Altria Group Inc have?
Altria Group Inc has 1,671,898,100 shares outstanding.
What happened to Altria Group Inc’s price movement after its last earnings report?
Altria Group Inc reported an EPS of €1.118 in its last earnings report, missing expectations of €1.134. Following the earnings report the stock price went down -4.06%.
Which hedge fund is a major shareholder of Altria Group Inc?
Currently, no hedge funds are holding shares in DE:PHM7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Altria Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€57.62 (-1.32% Downside)
€57.62 (-1.32% Downside)
Blogger Sentiment
Bullish
DE:PHM7 Sentiment 88%
Sector Average ―
Sector Average ―
News Sentiment
Bullish
Bullish news 67%
Bearish news 33%
Bearish news 33%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.82%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-0.45%
Trailing 12-Months
Company Description
Altria Group Inc
Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.
PHM7 Company Deck
PHM7 Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call conveyed a mix of positive strategic and financial developments alongside material near‑term challenges. Positives include full‑year EPS growth (4.4%), strong full‑year smokeable margins and net price realization, substantial shareholder returns (~$8B), progress in the nicotine pouch portfolio (ON and ON PLUS FDA authorizations and a planned national rollout), international expansion, and a clear plan to unlock import/export duty‑drawback benefits (with management citing <1 year payback). Offsetting these are meaningful cigarette volume declines (~9–10% FY adjusted), Q4 margin and adjusted OCI pressures in certain segments, intense competitive/promotional activity in nicotine pouches, a large $1.3B noncash e‑vapor impairment, and the ongoing industry headwind from illicit disposable e‑vapor products. Overall, the positives and negatives are roughly balanced — the company shows solid cash generation, strategic progress and guidance for modest EPS growth in 2026, but also faces significant operational and market headwinds that temper near‑term outlook.View all DE:PHM7 earnings summariesPHM7 Revenue Breakdown
88.00% Smokeable products
12.04% Oral tobacco products
-0.06% E-vapor products
0.02% All other
PHM7 Stock 12 Month Forecast
Average Price Target
€57.62
▼(-1.32% Downside)
Technical Analysis
British American Tobacco
―
Philip Morris
―
Universal
―
Turning Point Brands
―
RLX Technology
―
Options Prices
Currently, No data available
---